Data as of Aug 01
| -1.21 / -4.75%|
The 7 analysts offering 12-month price forecasts for Sagent Pharmaceuticals Inc have a median target of 27.00, with a high estimate of 33.00 and a low estimate of 20.00. The median estimate represents a +11.25% increase from the last price of 24.27.
The current consensus among 8 polled investment analysts is to Hold stock in Sagent Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.